Our findings concerning tyrosine hydroxylase provide evidence that supports the use of sympathomimetics to activate BAT in the treatment of diabetes, obesity, and other cardiometabolic disorders, as they illustrate the importance of innervation in the functionality of brown adipose tissue. The gene discussed is TH; the disease is diabetes mellitus.